您好,欢迎来到阿仪网! 请登录 免费注册

  • 高级会员服务
  • |
  • 广告位服务
  • |
  • 设为首页
  • |
  • 收藏本站
  • |
  • 诚信档案

    • 会员类型:旗舰版会员
    • 阿仪网旗舰版会员:9年
    • 工商认证【已认证】
    • 最后认证时间:
    • 注册号: 【已认证】
    • 法人代表: 【已认证】
    • 企业类型:经销商 【已认证】
    • 注册资金:人民币50万 【已认证】
    • 产品数:

上海雅吉生物科技有限公司 主营产品:ELISA试剂盒,免疫组化试剂盒,PCR检测盒,金标试纸,发光试剂盒,抗体,血清,细胞等

第9年

当前位置:阿仪网>上海雅吉生物科技有限公司>技术文章>文献引用产品:小鼠β淀粉样蛋白1-42抗体(Aβ1-42Ab)Elisa试剂盒

企业档案

会员类型:旗舰版

已获得阿仪网信誉   等级评定
90成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

阿仪网旗舰版会员:9年

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

参观次数:6395363

手机网站:http://wap.app17.com/c137908/

旗舰版网址:http://www.yajiml.com

技术文章

文献引用产品:小鼠β淀粉样蛋白1-42抗体(Aβ1-42Ab)Elisa试剂盒

点击次数:892 发布时间:2026/3/30 17:44:02

文章标题:Edaravone Dexborneol mitigates pathology in animal and cell culture models of Alzheimer’s disease by inhibiting neuroinflammation and neuronal necroptosis

作者列表:Xu Chong, Mei Yilan, Yang Ruihan, Luo Qiudan, Zhang Jienian, Kou Xiaolin, Hu Jianfeng, Wang Yujie, Li Yue, Chen Rong, Zhang Zhengping, Yao Yuyuan, Sima Jian

发表时间:2024-4-

期刊:Cell and Bioscience

影响因子:6.1

DOI:10.1186/s13578-024-01230-8

Abstract

Background

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease with limited disease-modifying treatments. Drug repositioning strategy has now emerged as a promising approach for anti-AD drug discovery. Using 5×FAD mice and Aβ-treated neurons in culture, we tested the efficacy of Y-2, a compounded drug containing the antioxidant Edaravone (Eda), a pyrazolone and (+)-Borneol, an anti-inflammatory diterpenoid from cinnamon, approved for use in amyotrophic lateral sclerosis patients.

Results

We examined effects of Y-2 versus Eda alone by i.p. administered in 8-week-old 5×FAD mice (females) for 4 months by comparing cognitive function, Aβ pathologies, neuronal necroptosis and neuroinflammation. Using primary neurons and astrocytes, as well as neuronal and astrocytic cell lines, we elucidated the molecular mechanisms of Y-2 by examining neuronal injury, astrocyte-mediated inflammation and necroptosis. Here, we find that Y-2 improves cognitive function in AD mice. Histopathological data show that Y-2, better than Eda alone, markedly ameliorates Aβ pathologies including Aβ burden, astrogliosis/microgliosis, and Tau phosphorylation. In addition, Y-2 reduces Aβ-induced neuronal injury including neurite damage, mitochondrial impairment, reactive oxygen species production and NAD+ depletion. Notably, Y-2 inhibits astrocyte-mediated neuroinflammation and attenuates TNF-α-triggered neuronal necroptosis in cell cultures and AD mice. RNA-seq further demonstrates that Y-2, compared to Eda, indeed upregulates anti-inflammation pathways in astrocytes.


原创作者:上海雅吉生物科技有限公司

推荐产品

在线咨询5分钟应答

提交